← Back to BIO

Bio-Rad Laboratories Inc. Class A financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSSep 2026Filed 04/11/2026Jun 2026Filed 04/11/2026Mar 2026Filed 04/11/2026Sep 2025Filed 04/11/2026Jun 2025Filed 04/11/2026Mar 2025Filed 04/11/2026Dec 2024Filed 14/02/2025Sep 2024Filed 29/10/2025
$656$651$592$653$652$585$668$650
$459$371−$527−$342$318$64−$716$653
$17.02$13.85−$19.55−$12.70$11.67$2.29−$25.57$23.34
272727272728—28

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.